Aimmune Therapeutics, which focuses on treatments for food allergies, announced Tuesday that its Phase 3 efficacy trial of AR101 met its primary endpoint for safety and efficacy.
The study tracked the health and habits of more than 357,000 Americans from 1985 to 2011.
In a news release issued Tuesday, the U.S. Centers for Disease Control and Prevention said that, along with several states and the U.S. Food and Drug Administration, it is "investigating a multista
The Food and Drug Administration said Tuesday it investigated complaints of illness and/or death in pets that ate Darwin's Natural and ZooLogics pet foods made by Arrow Reliance of Tukwila, Wash.
Nearly four out of 10 U.S. teens who use e-cigarettes said seeing others vape led them to try the devices themselves, according to a new report from the U.S. Centers for Disease Control and Prevent
Nearly $64 billion of that spending was for the development of 84 first-in-class drugs that use new biological mechanisms or targets.
Traditional concussion evaluation includes a CT scan of the head to detect any brain tissue damage. But many people who have such a scan do not have brain lesions that are detectable, the FDA said Wednesday in a news release.
Prostate cancer is the second-most-common form of the disease among men in the United States, the National Cancer Institute says. More than 161,000 men were diagnosed in 2017, and nearly 27,000 men
WEDNESDAY, Feb. 14, 2018 -- The "overmedication" of agitated dementia patients -- with the use of powerful antipsychotic drugs -- is an ongoing issue in U.S. health care.
The therapy -- known as cranial electrical stimulation, or CES -- involves a handheld device that delivers low-intensity electrical currents through electrodes placed on the head.